Kilkenny based life sciences company MyBio and commercial partner, German manufacturer MöLab GmbH, launched the Sars-COV-2 Neutralising Antibody Test (Nab) Test in the UK and Ireland — a finger-prick rapid test that can verify an individual’s antibody response to COVID-19 vaccines in just 10 minutes.
The test is a vaccination verification tool that will help identify people who, despite being vaccinated, may not have had an effective antibody response to vaccination and may still be exposed to the risk of COVID-19 infection — particularly as no one vaccine guarantees 100% immunity. The test will also be used to monitor the duration of vaccination protection, even for those who have responded positively to the vaccine.
The Sars-COV-2 NAb test detects "neutralizing" IgG antibodies that prevent SARS-CoV-2 from entering our cells, and measures the anti-SARS-CoV-2 immune response both after infection and after vaccination. To verify the response to the vaccine, the neutralising antibody test should be performed at least 10 days after the administration of the second dose of the vaccine.
Speaking about this new rapid test, MyBio Managing Director, Dr. Linda Nolan said "detecting NAbs in the population will assist in determining the effectiveness of vaccinations, and may provide indications about the length of immunity, herd immunity, and the need for possible booster doses.”
The möLab Sars-COV-2 NAb Test can detect neutralizing antibodies against SARS-CoV-2 with a specificity of 99.99%, a sensitivity of 99.9% and an accuracy of 99.99%. The test retails at €110/box of 10 tests and can be purchased on the MyBio website. ■
Domino’s Pizza has shuttered the last of its locations in Italy, officially ending a seven-year failed attempt to bring American fast-food pizza to the Mediterranean country from which the dish derives.